Following some notable uncertainty in recent years, M&A activity looks to be in recovery. In the first half of this year, biotech M&A activity saw some positive numbers, per a new J.P. Morgan report. That report cited a projection of some 100 M&A moves this year, among other improving data points for the space. Together, [...] The post Positive Biotech M&A Activity in 1H Boosts Case for Biotech ETF SBIO appeared first on ETF Trends .